Cosmos Health Inc. (NASDAQ: COSM) posted a second-quarter loss of $0.10 per share, missing analyst expectations by $0.11, as its revenue declined to $19.32 million, falling short of the $19.72 million consensus estimate.
The company’s earnings per share (EPS) of -$0.10 compared with the projected $0.01, marking a wider loss than the prior period. Revenue totaled $19.32 million, down from the $19.72 million forecast by analysts, reflecting weaker-than-expected sales performance.
Shares of Cosmos Health closed at $0.19 on Wednesday, extending declines of 23.56% over the past three months and 75.05% over the last 12 months. The stock’s prolonged downturn underscores persistent investor concerns over its financial trajectory.
Over the last 90 days, Cosmos Health received one positive EPS revision, with no negative adjustments, according to InvestingPro data. The company’s financial health score remains classified as "fair performance," indicating moderate operational stability amid ongoing challenges.
The earnings miss follows a period of subdued market sentiment toward the healthcare sector, where revenue volatility and margin pressures have weighed on smaller-cap stocks.
